Research Paper Volume 14, Issue 2 pp 907—922
A radiomics model predicts the response of patients with advanced gastric cancer to PD-1 inhibitor treatment
Figure 4. The radiomics nomogram for predicting anti-PD-1 efficacy in patients with advanced gastric cancer based on the rad-score with clinicopathological risk factors for CEA level and tumor metastasis site.